(September 19, 2018, 12:37 PM EDT) -- BROOKLYN, N.Y. — A New York federal judge on Sept. 17 dismissed without prejudice a whistleblower lawsuit alleging that an oncology center chain caused false claims to be submitted to federal health care programs for drugs made by Amgen Inc. (United States, ex rel. Joseph Piacentile, et al. v. Amgen, Inc., et al., No. 04-3983, E.D. N.Y., 2018 U.S. Dist. LEXIS 158126)....